The Center for iPS Cell Research and Application, Kyoto University (Director Shinya Yamanaka) and Hitachi, Ltd. (Headquarters, Tokyo, President Toshiaki Higashihara), a major electric appliance manufacturer, have agreed to cooperate in the construction of iPS cell panels for healthy people.In the future, we will build an iPS cell panel that will be a platform for medical applications of iPS cells based on blood and medical examination data collected by the Hitachi Health Management Center (Hitachi City, Ibaraki Prefecture) operated by Hitachi.
With this agreement, the Hitachi Health Care Center will solicit donors from healthy people who come to the health checkup, collect blood, and anonymize the checkup data and provide it to the iPS Cell Research Institute. The iPS Cell Research Institute will create iPS cells from blood cells and build a "Hitachi iPS Cell Panel" consisting of about 100 donors of various genders and age groups. Of the iPS cells, those with the consent of the donor will be deposited at the RIKEN BioResource Center of the public cell bank.The construction cost will be borne by the iPS Cell Research Institute.
Until now, the iPS Cell Research Institute has created iPS cells from cells of people with various diseases and deposited them in public cell banks to create an environment that can be used by many companies and researchers.However, in order to promote research, it is necessary to weigh iPS cells created from cells of healthy people who do not have these diseases, and iPS cells of healthy people and iPS cells of healthy people composed of data on health. Panel construction is indispensable.
Moreover, since it is necessary to confirm that the donor will not be sick in the future for the iPS cell panel of healthy subjects, it is necessary to obtain health data over a long period of time.Therefore, the iPS Cell Research Institute decided to build an iPS cell panel for healthy people in cooperation with Hitachi, which has a large amount of data on healthy people and has contributed to the development of medical care.
It is expected that the construction of iPS cell panels for healthy people will lead to the detailed elucidation of diseases that were previously unknown, such as the causes and progression of specific diseases, and the development of new treatment methods and drugs.
* IPS cell panel A comprehensive evaluation that reflects various genetic forms of iPS cells (induced pluripotent stem cells) created from human cells.
Source:[Center for iPS Cell Research and Application, Kyoto University] Hitachi and CiRA agree on cooperation for the construction of "healthy person iPS cell panel"